The PPI network analysis and further analyses in the GEPIA and UALCAN databases suggested that LCN2, LRG1, S100P, and TACSTD2 are both expressed and methylated in the plasma of CRC patients. This evidence concerns the gene LRG1 and colorectal carcinoma.